PGNY logo

PGNY Progyny, Inc.

NASDAQ Global Select · Medical - Healthcare Information Services · Healthcare

$26.28
+0.39 (+1.51%)

Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network …

Market Cap: $2.06Bwww.progyny.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

130
130
Aug 11Aug 11

Quote

Day Range
$25.73 – $26.46
52-Week Range
$16.10 – $33.06
Volume
$837.2K
Market Cap
$2.06B
50-Day Avg
$29.06
200-Day Avg
$23.78
Prev Close
$25.89
Open
$25.76

Valuation & Ratios

P/E Ratio
37.76
EPS
$0.69
P/B Ratio
4.24
P/S Ratio
1.70
Debt/Equity
0.05
Current Ratio
2.73
Dividend Yield
+0.0%
Gross Margin
+23.6%

Returns & Efficiency

Return on Equity
+11.3%
Return on Assets
+7.9%
FCF Yield
+8.8%
EV/EBITDA
20.96

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$1.29B$58.52M$0.68
2024$1.17B$54.34M$0.59
2023$1.09B$62.04M$0.65
2022$786.91M$30.36M$0.33
2021$500.62M$65.77M$0.74

Social Signal Score

80
5d
80
1 mentions
30d
80
1 mentions
60d
80
1 mentions
90d
80
1 mentions
news: 1

Earnings

Thu, Nov 5(in 3 months)

Consensus estimate $0.52 per share

7of 7 quarters beat consensus

Typical surprise +9.1% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 6$0.36 vs $0.33beat
  • Thu, May 7$0.30 vs $0.26beat
  • Thu, Feb 26$0.15 vs $0.15beat
  • Thu, Nov 6$0.45 vs $0.39beat
  • Thu, Aug 7$0.48 vs $0.44beat
  • Thu, May 8$0.48 vs $0.45beat

Estimates and results for PGNY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

Project earnings forward and see what return today's price implies.

Seeded from PGNY's reported EPS growth of -2.1% a year over 4 years.

EPS in 5 years
$0.62
Implied price
$23.46
Return from $26.28
-2.2% a year

To earn 15.0% a year on these assumptions you'd need to buy at $11.67 -55.6% below today's price.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E2632384450
-12.1%-18.6%-15.2%-12.2%-9.6%-7.3%
-7.1%-14.0%-10.4%-7.2%-4.5%-2.0%
-2.1%-9.4%-5.5%-2.2%0.7%3.3%
2.9%-4.8%-0.7%2.8%5.8%8.5%
7.9%-0.1%4.1%7.7%10.9%13.8%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (1)

  • Newsgurufocus.com·3d ago·Positive

    Progyny Inc (PGNY) Stock Down 4.6% -- Now Undervalued? GF Score: 93/100 On August 11, 2026, Progyny Inc (PGNY) shares fell by 4.6%, bringing the current price to $26.55. The stock has seen significant volatility, with a 52-week high

    View source ↗